Showing results (1231-1240 of 1,559) with videos related to
Sort By:
Pageof 156
Frontiers in Cardiovascular Medicine|January 23, 2024
Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspneaSarah Appleby, Chris Frampton, Mark Holdaway, et al.Acta Neuropathologica|July 24, 2024
Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion diseaseGannon A McDonough, Yuchen Cheng, Katherine S Morillo, et al.Journal of Medicinal Chemistry|May 23, 1997
Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacyT J Tucker, W C Lumma, S D Lewis, et al.Journal of the American Veterinary Medical Association|April 28, 2022
Complications and outcomes associated with laparoscopic-assisted splenectomy in dogsMarissa E S McGaffey, Ameet Singh, Nicole J Buote, et al.Plos One|May 25, 2013
Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factorsRui-Jun Su, David J Baylink, Amanda Neises, et al.Annals of Neurology|December 22, 2025
The Phenotypic Spectrum of Sporadic Creutzfeldt-Jakob Disease Cortical SubtypeSimone Baiardi, Claudia Marina Vargiu, Brian S Appleby, et al.Translational Psychiatry|April 11, 2013
Alterations in metabolic pathways and networks in Alzheimer's diseaseR Kaddurah-Daouk, H Zhu, S Sharma, et al.The American Journal of Gastroenterology|February 10, 2016
Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid DiarrheaIan M Johnston, Jonathan D Nolan, Sanjeev S Pattni, et al.Molecular Therapy. Methods & Clinical Development|June 16, 2025
The manufacture of AAV for gene therapy applications using a closed, semi-automated hollow-fiber bioreactorAdrien Soula, Florian Leseigneur, Amna Anwar, et al.Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A proteaseX Christopher Sheng, Todd Appleby, Thomas Butler, et al.Pageof 156